Table 1.
Baseline Characteristics of the Quality of Life Subset in the PROMISE Trial.
| Randomized Treatment Arm | |||
|---|---|---|---|
| Characteristic | Overall (N= 5985) |
Anatomic (N= 2982) |
Functional (N= 3003) |
| Mean age – years | 60.0 | 59.8 | 60.1 |
| Female sex (%) | 52.0 | 51.5 | 52.5 |
| Racial or ethnic minority (%) | 21.7 | 22.4 | 21.0 |
| Cardiac risk factor | |||
| Mean body mass index (kg/m2) | 29.7 | 29.6 | 29.9 |
| Hypertension (%) | 65.9 | 65.8 | 66.0 |
| Diabetes (%) | 21.2 | 21.2 | 21.2 |
| Dyslipidemia (%) | 67.9 | 67.3 | 68.4 |
| Family history of premature CAD (%) | 31.0 | 32.0 | 30.1 |
| Peripheral arterial or cerebrovascular disease (%) | 5.9 | 5.5 | 6.3 |
| CAD risk equivalent (%) | 25.4 | 24.9 | 25.8 |
| Metabolic syndrome (%) | 37.9 | 37.4 | 38.4 |
| Current or past tobacco use (%) | 51.5 | 51.6 | 51.4 |
| Sedentary lifestyle (%) | 51.4 | 51.6 | 51.3 |
| History of depression (%) | 21.1 | 20.2 | 22.0 |
| Relevant medication | |||
| Beta blocker (%) | 23.5 | 23.8 | 23.1 |
| ACE inhibitor or ARB (%) | 42.2 | 41.7 | 42.7 |
| Statin (%) | 44.7 | 44.5 | 44.8 |
| Aspirin (%) | 42.7 | 43.1 | 42.3 |
| Primary presenting symptom | |||
| Chest pain (%) | 73.3 | 74.2 | 72.5 |
| Dyspnea on exertion (%) | 15.4 | 14.8 | 15.9 |
| Other (%) | 11.3 | 11.0 | 11.6 |
| Type of angina | |||
| Typical (%) | 11.4 | 11.4 | 11.4 |
| Atypical (%) | 78.0 | 77.7 | 78.2 |
| Non-cardiac (%) | 10.6 | 10.9 | 10.4 |
CAD=coronary artery disease; ACE=angiotensin-converting enzyme; ARB=angiotensin II receptor blocker Race was self-reported on the clinical case report form.